Second Measles-Related Death in a Child Reported in Texas as US Cases Surpass 600
April 09, 2025

As the US measles outbreak tops 600 cases, Texas reported a second child's death in a young girl who was unvaccinated and had no underlying health conditions.

Closing the Gap in Lung Cancer Screening: Overcoming Barriers, Improving Early Detection
April 09, 2025

ACP 2025: Kim Sandler, MD, outlines key strategies to boost lung cancer screening uptake in primary care.

Primary Care Primer for Headache Management, with Morris Levin, MD
April 09, 2025

ACP 2025. The director of the UCSF Headache Center built an evidence-based framework for diagnosing and treating headache disorders seen in primary care.

Antibiotic Overuse for Asymptomatic UTIs: Daily Dose
April 09, 2025

Your daily dose of the clinical news you may have missed.

Navigating GLP-1 Medication Access: Coverage Challenges, Emerging Cash-Pay Options
April 08, 2025

ACP 2025: Laura Davisson, MD, outlines how PCPs can navigate GLP-1 medication coverage issues and why to consider recent cash-pay options.

Eisai Presents Real-World Lecanemab Data at AD/PD 2025 Confirming Phase 3 Clinical Trial Findings
April 08, 2025

In addition to support for phase 3 CLARITY AD findings, new evidence was presented supporting lecanemab safety and efficacy in ApoE ε4 carriers and non-carriers.

Bringing Mental Health into Primary Care: A Conversation with Matthew Press, MD
April 08, 2025

ACP 2025: Dr Press explains how primary care clinicians can implement the collaborative care model to integrate mental health services, improve outcomes, and navigate reimbursement.

Alphyn Biologics Initiates Phase 2b Trial of Botanical Drug for Atopic Dermatitis
April 08, 2025

The investigational botanical zabalafin hydrogel has shown antipruritic, antibacterial, and anti-inflammatory properties, addressing the multifactorial nature of AD.

ASCVD in Women is Different: A Review of Pathophysiology, Risk Factors, Presentation
April 08, 2025

ACP 2025. Karol E Watson, MD, PhD, highlighted how traditional approaches to CV care have poorly addressed the unique presentations, risk factors, and pathophysiology of heart disease in women.

Guselkumab (Tremfya) Gains FDA Approval for Crohn Disease: Daily Dose
April 08, 2025

Your daily dose of the clinical news you may have missed.